Company Search:
Advanced Search
Sponsored Links
Radnet, Inc. Company Snapshot
Radnet, Inc. operates within the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Radnet with three other pharmaceutical manufacturers in North America: Opko Health Incorporation (2018 sales of $990.27 million of which 82% was Diagnostics), Hypera SA ($1.02 billion ), and Indivior Plc ($1.01 billion of which 100% was Buprenorphine Based Drugs).

Sales Analysis. During the year ended December of 2018, sales at Radnet were $975.15 million. This is an increase of 5.7% versus 2017, when the company's sales were $922.19 million. This was the fifth consecutive year of sales increases at Radnet (and since 2013, sales have increased a total of 39%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Radnet, Inc.
  Stock Performance Chart for Radnet, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (10/18/2019): 15.04
(Figures in U.S. Dollars)
1 Week 3.9%   13 Weeks 0.4%  
4 Weeks 2.0%   52 Weeks -1.6%  
Radnet, Inc. Key Data:
  Ticker: RDNT Country: United States
  Exchanges: NAS Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2018 Sales 975,146,000
(Year Ending Jan 2019).
Employees: 6,342
  Currency: U.S. Dollars Market Cap: 753,913,599
  Fiscal Yr Ends: December Shares Outstanding: 50,127,234
  Share Type: Closely Held Shares: 8,663,563
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.